Concepedia
Statistics
Publications
19
Citations
609
H-Index
15
Active since
2015
Affiliations
Heidelberg University(Current)
University Hospital Heidelberg
German Cancer Research Center
University Medical Centre Mannheim
Central South University
Daniel Novak is an author at Heidelberg University specializing in oncology, molecular oncology, and medicine.
Publications per year
2015–2022
SOX2‐mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma
Laura Hüser, Sachindra Sachindra, Karol Granados et al. · International Journal of Cancer · 2018 · 72 citations · Full text
Medicine, Cancer Biology, Oncology +17
Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target
Elias Orouji, Aniello Federico, Lionel Larribère et al. · International Journal of Cancer · 2019 · 61 citations
Medicine, Molecular Biology, Oncology +17
NF1 loss induces senescence during human melanocyte differentiation in an <scp>iPSC</scp>‐based model
Lionel Larribère, Huizi Wu, Daniel Novak et al. · Pigment Cell & Melanoma Research · 2015 · 53 citations
Medicine, Cell Biology, Genetics +17
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma
Aniello Federico, Tamara Steinfass, Lionel Larribère et al. · Molecular Therapy — Oncolytics · 2020 · 48 citations · Full text
Medicine, Oncology, Pharmacology +17
Loss of neural crest‐associated gene <i>FOXD1</i> impairs melanoma invasion and migration <i>via RAC1B</i> downregulation
Huizi Wu, Lionel Larribère, Qian Sun et al. · International Journal of Cancer · 2018 · 45 citations · Full text
1–5 of 19